Cornercap Investment Counsel’s Collegium Pharmaceutical COLL Stock Holding History

Cornercap Investment Counsel’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,395	Closed	-$298K	–	217
2024 Q4	$298K	Hold	10,395	–	–	0.1%	363
2024 Q3	$402K	Sell	10,395 -11,611	-53%	-$414K	0.12%	297
2024 Q2	$709K	Sell	22,006 -170	-0.8%	-$5.89K	0.12%	312
2024 Q1	$861K	Buy	22,176 +174	+0.8%	+$6.09K	0.13%	295
2023 Q4	$677K	Buy	22,002 +959	+5%	+$24K	0.11%	338
2023 Q3	$470K	Buy	+21,043	New	+$480K	0.09%	414
2021 Q1	–	Sell	-42,635	Closed	-$877K	–	547
2020 Q4	$877K	Buy	+42,635	New	+$832K	0.13%	326
2020 Q1	–	Sell	-48,455	Closed	-$997K	–	401
2019 Q4	$997K	Buy	+48,455	New	+$808K	0.13%	314

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cornercap Investment Counsel's COLL Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of Collegium Pharmaceutical (COLL) in Q1 2025, closing a stake of 10,395 shares — an estimated $298K sold.

Cornercap Investment Counsel first reported a position in COLL in Q4 2019 and held it in 8 quarters. The position peaked at $997K in Q4 2019. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

Cornercap Investment Counsel reported no remaining Collegium Pharmaceutical position as of Q1 2025 after selling out during the quarter.
Cornercap Investment Counsel sold 10,395 Collegium Pharmaceutical shares in Q1 2025, an estimated $298K.
Cornercap Investment Counsel first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 8 quarters.
Cornercap Investment Counsel's Collegium Pharmaceutical position peaked at $997K in Q4 2019.
242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.